As expected ([38] and literature therein), dynamic parameters, such as response to therapy and especially failure to achieve complete remission, which are not obtainable at diagnosis, seem to be the most reliable outcome indicators in DLBCL, yet expression of CD5 and FOXP1 added information independent of these disease dynamic parameters. Here, CD5 is linked to diffuse large B-cell lymphoma.